Follow The Filings

ARR

Earnings company data as of 6:44 AM ET 10/22

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 28 Oct EPS 0.73 — —
Rev — — —

Insider trades

Open-market buys and sales by ARR's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ARR insider trades
  • $10K bought by 1 insider
  • $688K sold by 2 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Sergey Losyev Co-Chief Investment Officer
    Buy
    $10K 725 shares at $13.91 +8.1% to stake
    Traded Sep 29 Filed Sep 30
    ↗
  2. Daniel C Staton Chair
    Sale
    $564K 35,583 shares at $15.86 100% of stake
    Traded Sep 10 Filed Sep 11
    ↗
  3. Robert C Hain Director
    Sale
    $123K 6,833 shares at $18.06 87% of stake
    Traded Jan 6 Filed Jan 8
    ↗

Also filed in the last 12 months, not counted as buying or selling: 52 option exercises, 28 share withholdings for taxes, and 8 stock grants.

SEC filings

Recent issuer filings from EDGAR, 21 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
424B5 Filing Doc
8-K 1.01,5.03,8.01,9.01 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 1 day ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.